Sabrina Pagano studied Biological Sciences with Biotechnology specialization at the University “La Sapienza” of Rome (Italy). She received her PhD in “Endocrinology and Molecular Medicine” at the medical faculty of the University “La Sapienza”. She then spent two years at the Menarini Biotech pharmaceutical company in Italy. Later she joined the group of Professor Nicolas Vuilleumier in 2008 at the Laboratory Medicine Division at the Diagnostics Department of the Geneva University Hospital (Switzerland) where she is currently head of the research lab.
Her research focus is to investigate the role of the humoral autoimmunity in cardiovascular disease with a particular attention to the study of autoantibodies directed against anti-apolipoprotein A-1, the major protein fraction of HDL, as a biomarker and mediator of atherogenesis.
